Tolerance to Minimal Physical Activity in Adolescents With Systemic Lupus Erythematosus
Keywords:
systemic lupus erythematosus, six-minute walk test, adolescents
Abstract
In modern medicine, the issue of rheumatic diseases remains one of the most significant and socio-economically impactful problems due to the high rates of disability and loss of working capacity among these patients. The main cause of decreased quality of life and mortality in patients with systemic lupus erythematosus (SLE) is cardiovascular pathology, leading to the development of heart failure. An early symptom of myocardial dysfunction is the patient's loss of ability to perform routine physical activities in daily life. The aim of the study was to assess tolerance to minimal physical exertion in adolescents with systemic lupus erythematosus. A total of 46 adolescents with SLE were examined. They underwent the Six-Minute Walk Test (6MWT) with measurement of several parameters at rest and during the first minute of recovery following exertion.
Downloads
How to Cite
References
Nelly Ziade, Bernard El Khoury, Marouan Zoghbi, Georges Merheb, Ghada Abi Karam, Kamel Mroue', Jamil Messaykeh (2020) Prevalence and pattern of comorbidities in chronic rheumatic and musculoskeletal diseases: the COMORD study. 10(1), 7683.
Brian Løgstrup, Torkell Ellingsen, Alma Pedersen, Anders Kjærsgaard, Hans‐erik Bøtker, Michael Maeng (2018) Development of heart failure in patients with rheumatoid arthritis: A Danish population‐based study. 48(5), 12915.
Liu Yu, M Kaplan (2018) Cardiovascular disease in systemic lupus erythematosus: an update. 30(5), 441-448.
Medha Barbhaiya, Candace Feldman, Sarah Chen, Hongshu Guan, Michael Fischer, Brendan Everett, Karen Costenbader (2020) Comparative Risks of Cardiovascular Disease in Patients With Systemic Lupus Erythematosus, Diabetes Mellitus, and in General Medicaid Recipients. 72(10), 1431-1439.
Ntobeko Ntusi, Jane Francis, Emily Sever, Alexander Liu, Stefan Piechnik, Vanessa Ferreira, Paul Matthews, Matthew Robson, Paul Wordsworth, Stefan Neubauer, Theodoros Karamitsos (2018) Anti-TNF modulation reduces myocardial inflammation and improves cardiovascular function in systemic rheumatic diseases. 270, 253-259.
Joshua Lee, Premarani Sinnathurai, Rachelle Buchbinder, Catherine Hill, Marissa Lassere, Lyn March (2018) Biologics and cardiovascular events in inflammatory arthritis: a prospective national cohort study. 20(1), 171.
Th Mcdonagh, M Metra, M Adamo, R Gardner, A Baumbach, M Böhm, H Burri, A Skibelund, Esc (2021) Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC. 42(36), 3599-3726.
Del Castillo, S Shaddy, R Kantor, P (2019) Update on pediatric heart failure. 31(5), 598-603.
Peter Ubuane, Barakat Animasahun, Olufunke Ajiboye, Mogbafolu Kayode-Awe, Omotola Ajayi, Fidelis Njokanma (2018) The historical evolution of the six-minute walk test as a measure of functional exercise capacity: a narrative review. 3, 40-40.
Mario Kasović, Lovro Štefan, Vilko Petrić (2021) Normative data for the 6-min walk test in 11-14 year-olds: a population-based study. 21(1), 297-303.
N Shevchenko, L Bohmat, T Holovko, M Demianenko (2019) Adaptive capacity of the cardiovascular system in children with rheumatic diseases and comorbid conditions. 0(1), 99-105.
Laura Gochicoa-Rangel, Uri Mora-Romero, Selene Guerrero-Zúñiga, Mónica silva-Cerón, Silvia cid-Juárez, Mónica velázquez-Uncal, Adela durán-Cuéllar, Isabel salas-Escamilla, Roberto mejía-Alfaro, Luis torre-Bouscoulet (2019) Prueba de caminata de seis minutos: Recomendaciones y procedimientos. 78(S2), 164-172.
(1998) OECD Principles on Good Laboratory Practice. (1).
Motahareh Sheikh-Hosseini, Parisa Goodarzi, Hamid Aghayan, Kambiz Gilany, Firoozeh Ghaderi, Mahdi Gholami, Babak Arjmand (2020) Principles of Good Laboratory Practice (GLP). 17-35.
Jill Cash, Kelly Power-Kean (2017) Systemic Lupus Erythematosus (SLE), Canadian Guideline.
M Heartfailureriskassociatedwithrheumatoidarthritis -Relatedchronicinflammation / Ahlers (2020) Unknown Title. 9(10).
Vanessa Ocampo-Piraquive, Ivana Nieto-Aristizábal, Carlos Cañas, Gabriel Tobón (2018) Mortality in systemic lupus erythematosus: causes, predictors and interventions. 14(12), 1043-1053.
(2020) Pathogenetic association of vascular and cardiac lesions with systemic lupus erythematosus: characteristics and prevalence. 4(2), 6-15.
Angel López-Candales, Sawalha, ; Khalid, Luis Vila (2023) Inflammasomes as potential mediators of adverse cardiovascular events in diabetes and lupus: more questions than answers. 24(5), 279-282.
Tamar Klaiman, L Iannotte, Michael Josephs, Louise Russell, Laurie Norton, Shivan Mehta, Andrea Troxel, Jingsan Zhu, Kevin Volpp, David Asch (2023) Qualitative analysis of a remote monitoring intervention for managing heart failure. 23(1), 440.
Coziana Ciurtin, George Robinson, Maryam Butt, Junjie Peng, Stacy Ardoin, Laura Schanberg, Alina Boteanu, Katerina Bouchalova, Selcan Demir, Elena Moraitis, Angela Migowa, Yvonne Glackin, Jenny Ainsworth, Eve Smith, Elizabeth Jury, Sezgin Sahin, Sylvia Kamphuis, Laura Lewandowski (2024) Cardiovascular risk in young people with childhood onset systemic lupus erythematosus. 6(5), e258-e263.
Andrea Fava, Michelle Petri (2019) Systemic lupus erythematosus: Diagnosis and clinical management. 96, 1-13.
Hanna-Kaisa Aaramaa, Nina Mars, Mika Helminen, Anne Kerola, Antti Palomäki, Kari Eklund, Javier Gracia-Tabuenca, Juha Sinisalo, Finngen, Pia Isomäki (2024) Risk of cardiovascular comorbidities before and after the onset of rheumatic diseases. 65, 152382.
T Rasekaba, A Lee, M Naughton, T Williams, A Holland (2009) The six-minute walk test: a useful metric for the cardiopulmonary patient. 39(8), 495-501.
V Pepin, J Brodeur, Y Lacasse, J Milot, P Leblanc, F Whittom, F Maltais (2007) Six-minute walking versus shuttle walking: responsiveness to bronchodilation in chronic obstructive pulmonary disease. 62(4), 291-298.
Published
2026-01-09
Issue
Section
License
Copyright (c) 2025 Authors and Global Journals Private Limited

This work is licensed under a Creative Commons Attribution 4.0 International License.